Category
Cancer
Sub Category
Gynecologic
Study Name
GOG-0286B: A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC # 91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy For Measurable Stage III or IVA, Stage IVB,or Recurrent Endometrial Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance